切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (06) : 345 -349. doi: 10.3877/cma.j.issn.2095-3232.2014.06.004

所属专题: 机器人手术 文献

临床研究

机器人辅助胰头十二指肠切除术治疗胰头部恶性肿瘤
施昱晟1, 詹茜1, 邓侠兴1, 金佳斌1, 吴志翀1, 陈皓1, 沈柏用1, 彭承宏1,(), 李宏为1   
  1. 1. 200025 上海交通大学医学院附属瑞金医院普外科 上海交通大学医学院胰腺疾病研究所
  • 收稿日期:2014-08-15 出版日期:2014-12-10
  • 通信作者: 彭承宏
  • 基金资助:
    卫生部卫生行业科研专项(201002020); 上海市科委科研计划项目(11JC1407800)

Pancreaticoduodenectomy with assistance of robotic operation system for pancreatic head cancer

Yusheng Shi1, Qian Zhan1, Xiaxing Deng1, Jiabin Jin1, Zhichong Wu1, Hao Chen1, Baiyong Shen1, Chenghong Peng1,(), Hongwei Li1   

  1. 1. Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Research Institute of Pancreatic Diseases Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
  • Received:2014-08-15 Published:2014-12-10
  • Corresponding author: Chenghong Peng
  • About author:
    Corresponding author: Peng Chenghong, Email:
引用本文:

施昱晟, 詹茜, 邓侠兴, 金佳斌, 吴志翀, 陈皓, 沈柏用, 彭承宏, 李宏为. 机器人辅助胰头十二指肠切除术治疗胰头部恶性肿瘤[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(06): 345-349.

Yusheng Shi, Qian Zhan, Xiaxing Deng, Jiabin Jin, Zhichong Wu, Hao Chen, Baiyong Shen, Chenghong Peng, Hongwei Li. Pancreaticoduodenectomy with assistance of robotic operation system for pancreatic head cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(06): 345-349.

目的

探讨机器人辅助胰头十二指肠切除术治疗胰头部恶性肿瘤的临床应用价值。

方法

回顾性分析2010年5月至2014年4月上海瑞金医院应用达芬奇机器人辅助胰头十二指肠切除术治疗的38例胰头部恶性肿瘤患者临床资料。其中男25例,女13例;平均年龄(59±10)岁。所有患者均签署知情同意书,符合医学伦理学规定。采用"五孔法"置入3枚机器人专用套管(Trocar)及1枚镜头Trocar和1枚辅助Trocar,放入机器人臂,机器人辅助下行胰头十二指肠切除术。观察患者围手术期情况,包括手术时间、术中出血量、手术情况、术后并发症和生存情况等。

结果

38例均顺利完成,完全切除(R0)切除率97%(37/38),R1切除率3%(1/38),中位手术时间413(210~520)min,术中出血量320(50~1 100)ml,淋巴结清扫数15 (2~24)个。术后住院时间20 (7~36) d,术后并发症发生率42%(16/38),其中胰瘘8例、胆瘘2例、术后感染6例。术后生存时间25(3~42)个月,无瘤生存时间14(5~28)个月。

结论

采取机器人辅助胰头十二指肠切除术切除胰头部恶性肿瘤安全、可行。

Objective

To investigate the clinical application value of pancreaticoduodenectomy with the assistance of robotic operation system for pancreatic head cancer.

Methods

Clinical data of 38 patients with pancreatic head cancer undergoing pancreaticoduodenectomy using Da Vinci Si robotic system in Shanghai Ruijin Hospital from May 2010 to April 2014 were analyzed retrospectively. There were 25 males and 13 females with the mean age of (59±10) years old. The informed consents of all patients were obtained and the ethical committee approval was received. Three robotic exclusive Trocars, 1 camera Trocar and 1 assistant Trocar were inserted using 5-port approach and the robotic arms were inserted. Pancreaticoduodenectomy was performed under the assistance of robotic system. The perioperative situation including operation time, intraoperative blood loss, operation, postoperative complication and survive were observed.

Results

All the operations of 38 cases were finished successfully with radical (R0) resection rate 97% (37/38), R1 resection rate 3% (1/38) and the median operation time 413(210-520)min, intraoperative blood loss 320(50-1 100)ml, lymphnode clearance number 15(2-24), postoperative hospital stay 20(7-36)d. The incidence of postoperative complication was 42% (16/38) including pancreatic fistula (n=8), biliary fistula (n=2), postoperative infection (n=6). The postoperative survival time was 25(3-42) months and disease-free survival time was 14(5-28) months.

Conclusion

Pancreaticoduodenectomy with the assistance of robotic operation system is safe and feasible for resecting pancreatic head cancer.

图1 机器人辅助胰头十二指肠切除手术过程
[1]
Brennan DD, Zamboni GA, Raptopoulos VD, et al. Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT[J]. Radiographics, 2007, 27(6):1653-1666.
[2]
Vollmer CJ, Sanchez N, Gondek S, et al. A root-cause analysis of mortality following major pancreatectomy[J]. J Gastrointest Surg, 2012, 16(1):89-103.
[3]
Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial[J]. Ann Surg, 2011, 253(5):879-885.
[4]
Corcione F, Pirozzi F, Cuccurullo D, et al. Laparoscopic pancreaticoduodenectomy: experience of 22 cases[J]. Surg Endosc, 2013, 27(6):2131-2136.
[5]
卢榜裕,李建军.腹腔镜胰十二指肠切除术的发展现状与前景[J]. 微创医学,2010, 5(2):91-94.
[6]
沈柏用,刘钦,邓侠兴,等.达芬奇机器人手术系统行胰十二指肠切除术的临床疗效[J].中华消化外科杂志,2012, 11(1):79-81.
[7]
Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital[J]. Arch Surg, 2003, 138(7):777-784.
[8]
Buchs NC, Addeo P, Bianco FM, et al. Robotic versus open pancreaticoduodenectomy: a comparative study at a single institution[J]. World J Surg, 2011, 35(12):2739-2746.
[9]
周宁新,陈军周,刘全达,等.达芬奇机器人手术系统和开腹胰十二指肠切除术的比较[J].中华消化外科杂志,2010, 9(2):101-104.
[10]
Lai EC, Yang GP, Tang CN. Robot-assisted laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy: a comparative study[J]. Int J Surg, 2012, 10(9):475-479.
[11]
Chalikonda S, Aguilar-Saavedra JR, Walsh RM. Laparoscopic robotic-assisted pancreaticoduodenectomy: a case-matched comparison with open resection[J]. Surg Endosc, 2012, 26(9):2397-2402.
[12]
Lewis R, Drebin JA, Callery MP, et al. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma[J]. HPB, 2013, 15(1):49-60.
[13]
Konstantinidis IT, Deshpande V, Zheng H, et al. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?[J]. J Gastrointest Surg, 2010, 14(2):261-267.
[14]
Fatima J, Schnelldorfer T, Barton J, et al. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival[J]. Arch Surg, 2010, 145(2):167-172.
[15]
Jamieson NB, Chan NI, Foulis AK, et al. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma[J]. J Gastrointest Surg, 2013, 17(3):511-521.
[16]
Konstantinidis IT, Warshaw AL, Allen JN, et al. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? what is a "true" R0 resection?[J]. Ann Surg, 2013, 257(4):731-736.
[17]
Jamieson NB, Foulis AK, Oien KA, et al. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma[J]. Ann Surg, 2010, 251(6):1003-1010.
[1] 马桥桥, 张传开, 郭开今, 蒋涛, 王子豪, 刘勇, 郝亮. 可降解止血粉减少初次全膝关节置换术失血量的研究[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 585-589.
[2] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[3] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[4] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[9] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[10] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[11] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[12] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[13] 郭诗翔, 谭明达, 王槐志. 胰头癌淋巴结清扫再思考[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 625-628.
[14] 张昊, 潘卫东. 胰腺癌新辅助化疗后可切除性评估现状及进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 629-633.
[15] 周倜, 吴嘉, 韩方, 徐林伟, 张宇华. 新辅助治疗时代胰腺癌淋巴结清扫研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 634-639.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?